|
BIVM expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62492241884138E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.45439216225896E-14 |
| Normal-vs-Stage2 |
4.87630000045591E-07 |
| Normal-vs-Stage3 |
3.34177130412172E-14 |
| Normal-vs-Stage4 |
1.87109994165269E-10 |
| Stage1-vs-Stage2 |
3.792400E-01 |
| Stage1-vs-Stage3 |
5.296000E-02 |
| Stage1-vs-Stage4 |
2.937800E-01 |
| Stage2-vs-Stage3 |
4.730300E-02 |
| Stage2-vs-Stage4 |
1.540230E-01 |
| Stage3-vs-Stage4 |
7.092400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.640580E-04 |
| Normal-vs-Asian |
2.20929999994457E-06 |
| Caucasian-vs-AfricanAmerican |
1.439590E-01 |
| Caucasian-vs-Asian |
1.028070E-02 |
| AfricanAmerican-vs-Asian |
7.341600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.77029987627975E-10 |
| Normal-vs-Female |
1.6242562850266E-12 |
| Male-vs-Female |
3.478200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.66022751102446E-12 |
| Normal-vs-Age(41-60Yrs) |
6.91668944341473E-14 |
| Normal-vs-Age(61-80Yrs) |
1.3029000101028E-10 |
| Normal-vs-Age(81-100Yrs) |
2.00049999999896E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.396000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.933600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.045200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.160800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.635000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.045600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.827100E-04 |
| Classical-VS-Follicular |
4.926300E-02 |
| Classical-VS-Other |
9.144800E-01 |
| Classical-VS-Normal |
1.62714286489063E-12 |
| Tall-VS-Follicular |
2.22119999999659E-05 |
| Tall-VS-Other |
2.880800E-01 |
| Tall-VS-Normal |
7.105427357601E-15 |
| Follicular-VS-Other |
5.014600E-01 |
| Follicular-VS-Normal |
4.31669999967355E-07 |
| Other-VS-Normal |
2.542000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.79942735659233E-12 |
| Normal-vs-N1 |
6.71580013822393E-10 |
| N0-vs-N1 |
4.643200E-01 |
|
|
